183 related articles for article (PubMed ID: 11907272)
1. FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles.
Pendergrast PS; Wang C; Hernandez N; Huang S
Mol Biol Cell; 2002 Mar; 13(3):915-29. PubMed ID: 11907272
[TBL] [Abstract][Full Text] [Related]
2. The human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcription.
Young TM; Wang Q; Pe'ery T; Mathews MB
Mol Cell Biol; 2003 Sep; 23(18):6373-84. PubMed ID: 12944466
[TBL] [Abstract][Full Text] [Related]
3. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
4. MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner.
Michels AA; Nguyen VT; Fraldi A; Labas V; Edwards M; Bonnet F; Lania L; Bensaude O
Mol Cell Biol; 2003 Jul; 23(14):4859-69. PubMed ID: 12832472
[TBL] [Abstract][Full Text] [Related]
5. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.
Ramanathan Y; Reza SM; Young TM; Mathews MB; Pe'ery T
J Virol; 1999 Jul; 73(7):5448-58. PubMed ID: 10364292
[TBL] [Abstract][Full Text] [Related]
6. The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions.
Herrmann CH; Mancini MA
J Cell Sci; 2001 Apr; 114(Pt 8):1491-503. PubMed ID: 11282025
[TBL] [Abstract][Full Text] [Related]
7. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.
Romano G; Kasten M; De Falco G; Micheli P; Khalili K; Giordano A
J Cell Biochem; 1999 Dec; 75(3):357-68. PubMed ID: 10536359
[TBL] [Abstract][Full Text] [Related]
8. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
[TBL] [Abstract][Full Text] [Related]
9. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
Zhou Q; Chen D; Pierstorff E; Luo K
EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
[TBL] [Abstract][Full Text] [Related]
10. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat.
Fujinaga K; Cujec TP; Peng J; Garriga J; Price DH; Graña X; Peterlin BM
J Virol; 1998 Sep; 72(9):7154-9. PubMed ID: 9696809
[TBL] [Abstract][Full Text] [Related]
11. Developmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcription.
Wang Q; Young TM; Mathews MB; Pe'ery T
J Mol Biol; 2007 Mar; 367(3):630-46. PubMed ID: 17289077
[TBL] [Abstract][Full Text] [Related]
12. The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription.
Hoque M; Young TM; Lee CG; Serrero G; Mathews MB; Pe'ery T
Mol Cell Biol; 2003 Mar; 23(5):1688-702. PubMed ID: 12588988
[TBL] [Abstract][Full Text] [Related]
13. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.
Isel C; Karn J
J Mol Biol; 1999 Jul; 290(5):929-41. PubMed ID: 10438593
[TBL] [Abstract][Full Text] [Related]
14. Functional inactivation of Cdk9 through oligomerization chain reaction.
Napolitano G; Mazzocco A; Fraldi A; Majello B; Lania L
Oncogene; 2003 Jul; 22(31):4882-8. PubMed ID: 12894230
[TBL] [Abstract][Full Text] [Related]
15. A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat.
Brès V; Gomes N; Pickle L; Jones KA
Genes Dev; 2005 May; 19(10):1211-26. PubMed ID: 15905409
[TBL] [Abstract][Full Text] [Related]
16. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection.
Kanazawa S; Okamoto T; Peterlin BM
Immunity; 2000 Jan; 12(1):61-70. PubMed ID: 10661406
[TBL] [Abstract][Full Text] [Related]
17. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.
Barboric M; Yik JH; Czudnochowski N; Yang Z; Chen R; Contreras X; Geyer M; Matija Peterlin B; Zhou Q
Nucleic Acids Res; 2007; 35(6):2003-12. PubMed ID: 17341462
[TBL] [Abstract][Full Text] [Related]
18. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
Fujinaga K; Irwin D; Geyer M; Peterlin BM
J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex.
Kino T; Slobodskaya O; Pavlakis GN; Chrousos GP
J Biol Chem; 2002 Jan; 277(4):2396-405. PubMed ID: 11704662
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 tat transcriptional activity is regulated by acetylation.
Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
